Related Experiment Video
Updated: Aug 28, 2026

Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
Apparent Endoscopic Decrease in the Size of a Large Ulcerated Gastric Schwannoma After Helicobacter pylori
Takahito Awatsu1,2, Daisuke Asaoka2, Hirofumi Fukushima1
1Department of Gastroenterology Juntendo University Faculty of Medicine Tokyo Japan.
Abstract:
Gastric subepithelial lesions (SELs) comprise a heterogeneous group of tumors, among which gastric schwannomas are rare and generally benign. We report a case of a large gastric schwannoma with ulceration and symptomatic anemia that showed an apparent endoscopic decrease in size following Helicobacter pylori eradication. An 85-year-old man presented with iron deficiency anemia. Esophagogastroduodenoscopy revealed a large ulcerated SEL in the lower body of the stomach, along with multiple gastric ulcers. Endoscopic ultrasonography demonstrated a 56 mm tumor originating from the fourth layer, raising suspicion for a gastrointestinal stromal tumor. Boring biopsy from the ulcer base enabled a definitive diagnosis of gastric schwannoma based on immunohistochemical findings. Although surgical resection was recommended, the patient declined. After successful H. pylori eradication, follow-up endoscopy at 6 months showed healing of the ulcerative lesion and an apparent endoscopic decrease in the size of the tumor. Although objective post-treatment assessment was unavailable, this case suggests that inflammatory or ulcer-related changes associated with H. pylori infection may influence the endoscopic appearance of gastric SELs.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Gastritis II: Pathophysiology
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
